A Recombinant Human B Lymphocyte Stimulator Receptor-Immunoglobulin G (IgG ) Fc Fusion Protein in the Treatment of Subjects with Neuromyelitis Optica Spectrum Disorders: a Single Center, Randomized, Controlled Clinical Study
Latest Information Update: 04 Dec 2020
At a glance
- Drugs Telitacicept (Primary)
- Indications Neuromyelitis optica
- Focus Therapeutic Use
- 04 Dec 2020 New trial record